Brain inflammation has recently been shown to progress Alzheimer’s disease pathologies. Our studies aim to develop therapeutic strategies that suppress brain inflammation by developing a strategy that neutralizes proteins regulating the inflammatory response. We further aim to combine these strategies with gene therapy that will provide brain specificity and a long-term treatment approach. The ability to reduce brain inflammation without affecting the immune system is especially important for aging Alzheimer’s patients, who may already have a compromised immune system.
